Evidence map›Paper›PMID 24463512›Full record

ArticleNature2014

A discrete genetic locus confers xyloglucan metabolism in select human gut Bacteroidetes.

Johan Larsbrink, Theresa E Rogers, Glyn R Hemsworth, Lauren S McKee, Alexandra S Tauzin, Oliver Spadiut, Stefan Klinter, Nicholas A Pudlo, Karthik Urs, Nicole M Koropatkin and 7 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 240 papers.

0numbers the graph read from it
0cells of the map it votes in
240citing papers in PubMed
18.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

240 citing papers in PubMed, 509 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Discovery of a secretedGut microbes · 2026
    Article
  5. Article
  6. Extracellular metabolite production byApplied and environmental microbiology · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. A system for transferring large genetic loci inApplied and environmental microbiology · 2026
    Article
  11. Reverse prediction of carbohydrate esterase polysaccharide targets.Biotechnology for biofuels and bioproducts · 2026
    Article
  12. Article
  13. Review
  14. A Hadza-enrichedGut microbes reports · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Glycoside hydrolase-mediated glucomannan catabolism inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Article
  20. Article

180 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 4 countries.

Johan Larsbrink1] Division of Glycoscience, School of Biotechnology, Royal Institute of Technology (KTH), AlbaNova University Centre, 106 91 Stockholm, Sweden [2].
Theresa E Rogers1] Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA [2].
Glyn R Hemsworth1] Structural Biology Laboratory, Department of Chemistry, University of York, York YO10 5DD, UK [2].
Lauren S McKee1] Division of Glycoscience, School of Biotechnology, Royal Institute of Technology (KTH), AlbaNova University Centre, 106 91 Stockholm, Sweden [2] Wallenberg Wood Science Center, Royal Institute of Technology (KTH), Teknikringen 56-58, 100 44 Stockholm, Sweden.
Alexandra S TauzinMichael Smith Laboratories and Department of Chemistry, University of British Columbia, 2185 East Mall, Vancouver, British Columbia V6T 1Z4, Canada.
Oliver Spadiut1] Division of Glycoscience, School of Biotechnology, Royal Institute of Technology (KTH), AlbaNova University Centre, 106 91 Stockholm, Sweden [2] Wallenberg Wood Science Center, Royal Institute of Technology (KTH), Teknikringen 56-58, 100 44 Stockholm, Sweden.
Stefan KlinterDivision of Glycoscience, School of Biotechnology, Royal Institute of Technology (KTH), AlbaNova University Centre, 106 91 Stockholm, Sweden.
Nicholas A PudloDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
Karthik UrsDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
Nicole M KoropatkinDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
A Louise CreaghMichael Smith Laboratories and Department of Chemical and Biological Engineering, University of British Columbia, 2185 East Mall, Vancouver, British Columbia V6T 1Z4, Canada.
Charles A HaynesMichael Smith Laboratories and Department of Chemical and Biological Engineering, University of British Columbia, 2185 East Mall, Vancouver, British Columbia V6T 1Z4, Canada.
Amelia G KellyDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
Stefan Nilsson CederholmDivision of Glycoscience, School of Biotechnology, Royal Institute of Technology (KTH), AlbaNova University Centre, 106 91 Stockholm, Sweden.
Gideon J DaviesStructural Biology Laboratory, Department of Chemistry, University of York, York YO10 5DD, UK.
Eric C MartensDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
Harry Brumer1] Division of Glycoscience, School of Biotechnology, Royal Institute of Technology (KTH), AlbaNova University Centre, 106 91 Stockholm, Sweden [2] Michael Smith Laboratories and Department of Chemistry, University of British Columbia, 2185 East Mall, Vancouver, British Columbia V6T 1Z4, Canada.
University of Michigan · USAlbaNova · SEKTH Royal Institute of Technology · SEUniversity of British Columbia · CAUniversity of York · GB

Funding

How glycans shape gut microbiota function and assemblyR01GM099513 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARTENS, ERIC C · 2013 to 2016
$1.2M
Complex glycan utilization by human gut BacteroidesK01DK084214 · NIDDK · WASHINGTON UNIVERSITY · PI MARTENS, ERIC C · 2009 to 2013
$584k
Biotechnology and Biological Sciences Research Council BB/I014802/1NIDDK NIH HHS DK084214NIDDK NIH HHS K01 DK084214NIGMS NIH HHS GM099513NIGMS NIH HHS R01 GM099513
6 · The paper itself

Abstract

A well-balanced human diet includes a significant intake of non-starch polysaccharides, collectively termed 'dietary fibre', from the cell walls of diverse fruits and vegetables. Owing to the paucity of alimentary enzymes encoded by the human genome, our ability to derive energy from dietary fibre depends on the saccharification and fermentation of complex carbohydrates by the massive microbial community residing in our distal gut. The xyloglucans (XyGs) are a ubiquitous family of highly branched plant cell wall polysaccharides whose mechanism(s) of degradation in the human gut and consequent importance in nutrition have been unclear. Here we demonstrate that a single, complex gene locus in Bacteroides ovatus confers XyG catabolism in this common colonic symbiont. Through targeted gene disruption, biochemical analysis of all predicted glycoside hydrolases and carbohydrate-binding proteins, and three-dimensional structural determination of the vanguard endo-xyloglucanase, we reveal the molecular mechanisms through which XyGs are hydrolysed to component monosaccharides for further metabolism. We also observe that orthologous XyG utilization loci (XyGULs) serve as genetic markers of XyG catabolism in Bacteroidetes, that XyGULs are restricted to a limited number of phylogenetically diverse strains, and that XyGULs are ubiquitous in surveyed human metagenomes. Our findings reveal that the metabolism of even highly abundant components of dietary fibre may be mediated by niche species, which has immediate fundamental and practical implications for gut symbiont population ecology in the context of human diet, nutrition and health.

Indexed as

Amino Acid SequenceBacteroidesCarbohydrate MetabolismCarbohydrate SequenceCell WallCrystallography, X-RayDietDietary FiberEvolution, MolecularGastrointestinal TractGenetic LociGlucansGlycoside HydrolasesHumansMetagenomeModels, MolecularDietary FiberGlucansGlycoside HydrolasesXylansxyloglucanxyloglucan endo(1-4)-beta-D-glucanase

Identifiers

PMID24463512
PMCPMC4282169
OpenAlexW1971738871

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.